Sjögren syndrome and systemic lupus erythematosus are distinct conditions

Dermatology Online Journal

Volumn 12, Issue 1, 2006, Pages

  Scheinfeld, Noah ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; RO ANTIBODY;

CLINICAL EXAMINATION; CLINICAL FEATURE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; HAPLOTYPE; HLA MATCHING; HLA SYSTEM; HUMAN; LYMPHOMA; PARVOVIRUS; PHOTOSENSITIVITY; REPRODUCIBILITY; REVIEW; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 32244440986     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Daniels TE. Sjögren's syndrome: clinical spectrum and current diagnostic controversies.Adv Dent Res. 1996 Apr;10(1):3-8.
2. http://www.Sjögrensyndrom.se/100-site/spdfs/S1.pdf (accessed January 1,2006)
3. Narbutt J. Sjogen's Syndrome. http://www.emedicine.com/derm/topic846.htm. (accessed January 1,2006)
4. Sontheimer RD. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol. 1996;63:583-94.
5. Pease CT, Shattles W, Charles PJ, Venables PJ, Maini RN. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome. Clin Exp Rheumatol. 1989;7(2):185-90.
6. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004 Jun 28;164 (12):1275-84.
7. Pedersen AM, Nauntofte B. Primary Sjögren's syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy. Expert Opin Pharmacother. 2001 Sep;2(9):1415-36.
8. Rehman HU. Sjögren's syndrome. Yonsei Med J. 2003 Dec 30;44(6):947-54.
9. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004 Sep;83(5):280-91.
10. Reddy KS, Jha V, Nada R, Kohli HS, Sud K, Gupta KL, Sakhuja V. Respiratory paralysis in Sjögren syndrome with normal renal function. Natl Med J India. 2003 Sep-Oct;16(5):253-4.
11. Nikitakis NG, Rivera H, Lariccia C, Papadimitriou JC, Sauk JJ. Primary Sjögren syndrome in childhood: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jul;96(1):42-7.
12. Xu K, Kazuo T. Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome. Zhonghua Yan Ke Za Zhi. 1997 May;33(3):222-5.
13. Schiodt M, Thorn J. Criteria for the salivary component of Sjögren's syndrome. A review. Clin Exp Rheumatol. 1989 Mar-Apr;7(2):119-22.
14. Bodeutsch C, de Wilde PC, Kater L, van Houwelingen JC, van den Hoogen FH, Kruize AA, Hene RJ, van de Putte LB, Vooijs GP. Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome. Arthritis Rheum. 1992 Sep;35(9):1075-87.
15. Martin-Martin LS, Latini A, Pagano A, Ragno A, Stasi R, Coppe A, Davoli G, Crescenzi A, Alimonti A, Migliore A. A new mathematical model based on clinical and laboratory variables for the diagnosis of Sjögren's syndrome. Clin Rheumatol. 2003 May;22(2):123-6.
16. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med. 2003;14(2):115-27.
17. Loustaud-Ratti V, Riche A, Liozon E, Labrousse F, Soria P, Rogez S, Babany G, Delaire L, Denis F, Vidal E. Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol. 2001 Oct;28(10):2245-51.
18. De Stefano R, Manganelli S, Frati E, Selvi E, Azzi A, Zakrzewska K, Marcolongo R. No association between human parvovirus B19 infection and Sjögren's syndrome. Ann Rheum Dis. 2003 Jan;62(1):86-7.
19. De Re V, De Vita S, Battistella V, Marzotto A, Libra M, Ferraccioli G, Boiocchi M. Absence of human parvovirus B19 DNA in myoepithelial sialadenitis of primary Sjögren's syndrome. Ann Rheum Dis. 2002 Sep;61(9):855-6.
20. Ramos-Casals M, Cervera R, Garcia-Carrasco M, Vidal J, Trejo O, Jimenez S, Costa J, Font J, Ingelmo M. Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome. Semin Arthritis Rheum. 2000 Jun;29(6):373-8.
21. Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001 Feb;40(2):152-7.
22. Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, Menkes CJ, Meyer O, Charron D, Goldberg D. HLA class I and class II are both associated with the genetic predisposition to primary Sjögren syndrome. Hum Immunol. 2001 Jul;62(7):725-31.
23. Zandbelt MM, van den Hoogen FH, de Wilde PC, van den Berg PJ, Schneider HG, van de Putte LB. Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndrome. Ann Rheum Dis. 2001 May;60(5):511-3.
24. Kruize AA, Hene RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, Bijlsma JW. Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. Ann Rheum Dis. 1993 May;52(5):360-4.
25. Thouret MC, Sirvent N, Triolo V, Monteilh C, Michiels J, Boutte P. Primary Gougerot-Sjögren syndrome in a 13-year-old girl Arch Pediatr. 2002 Feb;9(2):142-6.
26. Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis. 1999 Apr;58(4):253-6.
27. Fox RI, Dixon R, Guarrasi V, Krubel S. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus. 1996 Jun;5 Suppl 1:S31-6.
28. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. N Engl J Med. 1991 Jan 17;324(3):150-4.
29. Saito T, Sato J, Kondo K, Horikawa M, Ohmori K, Fukuda H. Low prevalence of clinicopathologic and sialographic changes in salivary glands of men with Sjögren's syndrome. J Oral Pathol Med. 1999 Aug;28(7):312-6.
30. Janin A, Morel P, Quiquandon I, Farre I, Hatron PY, Bauters F, Gosselin B. Non-Hodgkin's lymphoma and Sjögren's syndrome. An immunopathological study of 113 patients. Clin Exp Rheumatol. 1992 Nov-Dec;10(6):565-70.
31. Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P. Cutaneous manifestations of primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol. 2004 Sep-Oct;22(5):632-6.
32. Callen J. Lupus Erythematosus, Subacute Cutaneous. http://www. emedicine.com/derm/topic248.htm (Accessed January 1, 2006)
33. Browne C. Lupus Erythematosus, Acute http://www.emedicine.com/ DERM/topic245.htm (Accessed January 1, 2006)